Selected Grants
Protect IV
Clinical TrialPrincipal Investigator · Awarded by Abiomed, Inc. · 2024 - 2028Implementation of a Medication Adherence Instrument among Patients with Symptomatic Peripheral Artery Disease after Peripheral Vascular Intervention
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2028ARTEMIS - Site
Clinical TrialPrincipal Investigator · Awarded by Novo Nordisk, Inc. · 2024 - 2028A multicenter,international,randomized,active comparator-controlled,double-blind,doubledummy, parallel-group,2-arm,Phase3 study to compare the efficacy and safety of the oral FXIa inhibitor asundexian(BAY 2433334) with apixaban for the prevention
Clinical TrialCo Investigator · Awarded by Bayer Healthcare Pharmaceuticals Inc · 2023 - 2027SOS-AMI
Clinical TrialPrincipal Investigator · Awarded by Idorsia Pharmaceuticals Ltd · 2022 - 2026Protect IV
Clinical TrialPrincipal Investigator · Awarded by Abiomed, Inc. · 2024 - 2028Implementation of a Medication Adherence Instrument among Patients with Symptomatic Peripheral Artery Disease after Peripheral Vascular Intervention
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2028ARTEMIS - Site
Clinical TrialPrincipal Investigator · Awarded by Novo Nordisk, Inc. · 2024 - 2028A multicenter,international,randomized,active comparator-controlled,double-blind,doubledummy, parallel-group,2-arm,Phase3 study to compare the efficacy and safety of the oral FXIa inhibitor asundexian(BAY 2433334) with apixaban for the prevention
Clinical TrialCo Investigator · Awarded by Bayer Healthcare Pharmaceuticals Inc · 2023 - 2027SOS-AMI
Clinical TrialPrincipal Investigator · Awarded by Idorsia Pharmaceuticals Ltd · 2022 - 2026Patient Advisory Board and Faculty Effort across multiple studies
Clinical TrialPrincipal Investigator · Awarded by Abiomed · 2023 - 20251/2 Low dose colchicine in pAtients with peripheral artery DiseasE to assess residual vascular risk (LEADER-PAD)
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2024 - 2025TCT 2024 DCRI Symposium (for the CAMEO Registry)
Clinical TrialPrincipal Investigator · Awarded by Chiesi USA, Inc · 2024 - 2024Cath-PCI Registry
ResearchPrincipal Investigator · Awarded by American College of Cardiology · 2015 - 2024Cameo Registry Manuscript only
Clinical TrialPrincipal Investigator · Awarded by Chiesi USA, Inc · 2022 - 2024CathPCI Year 2023
Clinical TrialPrincipal Investigator · Awarded by American College of Cardiology Foundation · 2015 - 2024Validating the Peripheral Artery Questionnaire and Vascular Quality of Life Questionnaire in a Population of Patients with Chronic Limb Threatening Ischemia
ResearchPrincipal Investigator · Awarded by Vascular Cures · 2021 - 2023Implementation of a Medication Adherence Instrument Among Patients with Symptomatic Peripheral Artery Disease after PVI
ResearchPrincipal Investigator · Awarded by American Heart Association · 2022 - 2023ACCF Keating Award
FellowshipPrincipal Investigator · Awarded by American College of Cardiology Foundation · 2018 - 2019External Relationships
- Abbott (St. Jude Medical)
- Chiesi USA
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.